Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 434

    1.

    Safety and efficacy of once-daily nevirapine dosing: a multicohort study.

    Calmy A, Vallier N, Nguyen A, Lange JM, Battegay M, de Wolf F, Reiss P, Lima VD, Hirschel B, Hogg RS, Yip B, Montaner JS, Wit FW; Swiss HIV Cohort study; HAART Observational Medical Evaluation and Research Cohort; the Netherlands ATHENA Observational Cohort.

    Antivir Ther. 2009;14(7):931-938.PMID: 19918097 [PubMed - as supplied by publisher]Related articles

    2.

    An assessment of global Internet-based HIV/AIDS media coverage: implications for United Nations Programme on HIV/AIDS' Global Media HIV/AIDS Initiative.

    Anema A, Freifeld CC, Druyts E, Montaner JS, Hogg RS, Brownstein JS.

    Int J STD AIDS. 2009 Oct 15. [Epub ahead of print]PMID: 19833689 [PubMed - as supplied by publisher]Related articles

    3.

    Poor agreement between 2 assays for measuring low levels of HIV-1 viral load.

    Montaner JS, Richman DD, Hammer SM; International AIDS Society-USA Antiretroviral Guidelines Panel.

    Clin Infect Dis. 2009 Oct 15;49(8):1283-4. No abstract available. PMID: 19780662 [PubMed - indexed for MEDLINE]Related articles

    4.

    The association between food insecurity and mortality among HIV-infected individuals on HAART.

    Weiser SD, Fernandes KA, Brandson EK, Lima VD, Anema A, Bangsberg DR, Montaner JS, Hogg RS.

    J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):342-9.PMID: 19675463 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers.

    Shannon K, Kerr T, Strathdee SA, Shoveller J, Montaner JS, Tyndall MW.

    BMJ. 2009 Aug 11;339:b2939. doi: 10.1136/bmj.b2939.PMID: 19671935 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting.

    Kim C, Kerr T, Li K, Zhang R, Tyndall MW, Montaner JS, Wood E.

    BMC Public Health. 2009 Jul 29;9:270.PMID: 19640297 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Harm reduction in hospitals: is it time?

    Rachlis BS, Kerr T, Montaner JS, Wood E.

    Harm Reduct J. 2009 Jul 29;6:19.PMID: 19638238 [PubMed - in process]Related articlesFree article

    8.

    Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy.

    Pfeffer G, Côté HC, Montaner JS, Li CC, Jitratkosol M, Mezei MM.

    Neurology. 2009 Jul 7;73(1):71-2. No abstract available. PMID: 19564587 [PubMed - indexed for MEDLINE]Related articles

    9.

    Does ratification of human-rights treaties have effects on population health?

    Palmer A, Tomkinson J, Phung C, Ford N, Joffres M, Fernandes KA, Zeng L, Lima V, Montaner JS, Guyatt GH, Mills EJ.

    Lancet. 2009 Jun 6;373(9679):1987-92.PMID: 19501746 [PubMed - indexed for MEDLINE]Related articles

    10.

    Injection drug use among street-involved youth in a Canadian setting.

    Kerr T, Marshall BD, Miller C, Shannon K, Zhang R, Montaner JS, Wood E.

    BMC Public Health. 2009 Jun 3;9:171.PMID: 19493353 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

    Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine Toxicity Multicohort Collaboration.

    AIDS. 2009 Aug 24;23(13):1689-99.PMID: 19487907 [PubMed - in process]Related articles

    12.

    Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis.

    Milloy MJ, Buxton J, Wood E, Li K, Montaner JS, Kerr T.

    BMC Public Health. 2009 May 27;9:156.PMID: 19473508 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

    Wood E, Kerr T, Marshall BD, Li K, Zhang R, Hogg RS, Harrigan PR, Montaner JS.

    BMJ. 2009 Apr 30;338:b1649. doi: 10.1136/bmj.b1649.PMID: 19406887 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Determinants of cutaneous injection-related infection care at a supervised injecting facility.

    Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

    Ann Epidemiol. 2009 Jun;19(6):404-9. Epub 2009 Apr 11.PMID: 19364660 [PubMed - indexed for MEDLINE]Related articles

    15.

    The war on drugs: a devastating public-policy disaster.

    Wood E, Werb D, Marshall BD, Montaner JS, Kerr T.

    Lancet. 2009 Mar 21;373(9668):989-90. Epub 2009 Mar 11. No abstract available. PMID: 19282025 [PubMed - indexed for MEDLINE]Related articles

    16.

    HIV/AIDS in Vancouver, British Columbia: a growing epidemic.

    McInnes CW, Druyts E, Harvard SS, Gilbert M, Tyndall MW, Lima VD, Wood E, Montaner JS, Hogg RS.

    Harm Reduct J. 2009 Mar 5;6:5.PMID: 19265531 [PubMed - in process]Related articlesFree article

    17.

    Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay.

    Lima V, Harrigan R, Montaner JS.

    J Acquir Immune Defic Syndr. 2009 May 1;51(1):3-6.PMID: 19247185 [PubMed - indexed for MEDLINE]Related articles

    18.

    The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

    Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, Yip B, Montaner JS.

    J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):529-36.PMID: 19223785 [PubMed - indexed for MEDLINE]Related articles

    19.

    Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda.

    Kiboneka A, Nyatia RJ, Nabiryo C, Anema A, Cooper CL, Fernandes KA, Montaner JS, Mills EJ.

    BMJ. 2009 Feb 17;338:b201. doi: 10.1136/bmj.b201.PMID: 19223338 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals.

    Lima VD, Fink V, Yip B, Hogg RS, Harrigan PR, Montaner JS.

    Am J Public Health. 2009 Apr;99 Suppl 1:S193-6. Epub 2009 Feb 12.PMID: 19218172 [PubMed - indexed for MEDLINE]Related articles

    21.

    Mortality is influenced by locality in a major HIV/AIDS epidemic.

    Druyts EF, Rachlis BS, Lima VD, Harvard SS, Zhang W, Brandson EK, Strathdee SA, Montaner JS, Hogg RS.

    HIV Med. 2009 May;10(5):274-81. Epub 2009 Feb 5.PMID: 19210694 [PubMed - in process]Related articles

    22.

    Health care services utilization stratified by virological and immunological markers of HIV: evidence from a universal health care setting.

    Druyts EF, Yip B, Lima VD, Burke TA, Lesovski D, Fernandes KA, McInnes CW, Rustad CA, Montaner JS, Hogg RS.

    HIV Med. 2009 Feb;10(2):88-93.PMID: 19200171 [PubMed - in process]Related articles

    23.

    Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation.

    Hull MW, Harris M, Lima V, Guillemi S, Harrigan PR, Montaner JS.

    J Clin Pharmacol. 2009 Feb;49(2):155-61.PMID: 19179294 [PubMed - indexed for MEDLINE]Related articles

    24.

    Structural factors associated with an increased risk of HIV and sexually transmitted infection transmission among street-involved youth.

    Marshall BD, Kerr T, Shoveller JA, Montaner JS, Wood E.

    BMC Public Health. 2009 Jan 9;9:7.PMID: 19134203 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Access to drug and alcohol treatment among a cohort of street-involved youth.

    Hadland SE, Kerr T, Li K, Montaner JS, Wood E.

    Drug Alcohol Depend. 2009 Apr 1;101(1-2):1-7. Epub 2008 Dec 9.PMID: 19081203 [PubMed - indexed for MEDLINE]Related articles

    26.

    Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.

    Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

    BMC Public Health. 2008 Dec 9;8:405.PMID: 19068133 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Changing global epidemiology of pulmonary manifestations of HIV/AIDS.

    Hull MW, Phillips P, Montaner JS.

    Chest. 2008 Dec;134(6):1287-98. Review.PMID: 19059959 [PubMed - indexed for MEDLINE]Related articles

    28.

    High prevalence of HIV infection among homeless and street-involved Aboriginal youth in a Canadian setting.

    Marshall BD, Kerr T, Livingstone C, Li K, Montaner JS, Wood E.

    Harm Reduct J. 2008 Nov 19;5:35.PMID: 19019253 [PubMed - in process]Related articlesFree article

    29.

    Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.

    Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, Olupot-Olupot P, Joffres M, Anema A, Cooper CL, Montaner JS, Mills EJ.

    AIDS. 2008 Nov 30;22(18):2493-9.PMID: 19005272 [PubMed - indexed for MEDLINE]Related articles

    30.

    CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy.

    Moore DM, Awor A, Downing R, Kaplan J, Montaner JS, Hancock J, Were W, Mermin J.

    J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):477-84.PMID: 18989232 [PubMed - indexed for MEDLINE]Related articles

    31.

    Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.

    Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS.

    AIDS. 2008 Nov 12;22(17):2371-80.PMID: 18981777 [PubMed - indexed for MEDLINE]Related articles

    32.

    The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.

    Tam LW, Chui CK, Brumme CJ, Bangsberg DR, Montaner JS, Hogg RS, Harrigan PR.

    J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):266-71.PMID: 18845950 [PubMed - indexed for MEDLINE]Related articles

    33.

    Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART.

    Fielden SJ, Rusch ML, Yip B, Wood E, Shannon K, Levy AR, Montaner JS, Hogg RS.

    J Int Assoc Physicians AIDS Care (Chic Ill). 2008 Sep-Oct;7(5):238-44. Epub 2008 Sep 23.PMID: 18812590 [PubMed - indexed for MEDLINE]Related articles

    34.

    Condom use among injection drug users accessing a supervised injecting facility.

    Marshall BD, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

    Sex Transm Infect. 2009 Apr;85(2):121-6. Epub 2008 Sep 23.PMID: 18812391 [PubMed - indexed for MEDLINE]Related articles

    35.

    Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.

    Lloyd-Smith E, Wood E, Li K, Montaner JS, Kerr T.

    Drug Alcohol Depend. 2009 Jan 1;99(1-3):176-82. Epub 2008 Sep 20.PMID: 18805655 [PubMed - indexed for MEDLINE]Related articles

    36.

    Exacerbation of depression associated with starting raltegravir: a report of four cases.

    Harris M, Larsen G, Montaner JS.

    AIDS. 2008 Sep 12;22(14):1890-2. No abstract available. PMID: 18753871 [PubMed - indexed for MEDLINE]Related articles

    37.

    Characteristics of injection drug users who participate in drug dealing: implications for drug policy.

    Kerr T, Small W, Johnston C, Li K, Montaner JS, Wood E.

    J Psychoactive Drugs. 2008 Jun;40(2):147-52.PMID: 18720663 [PubMed - indexed for MEDLINE]Related articles

    38.

    Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

    Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA; International AIDS Society-USA.

    JAMA. 2008 Aug 6;300(5):555-70.PMID: 18677028 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

    Wood E, Hogg RS, Lima VD, Kerr T, Yip B, Marshall BD, Montaner JS.

    JAMA. 2008 Aug 6;300(5):550-4.PMID: 18677027 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    The use of highly active retroviral therapy to reduce HIV incidence at the population level.

    Anema A, Wood E, Montaner JS.

    CMAJ. 2008 Jul 1;179(1):13-4. No abstract available. PMID: 18591515 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.

    Milloy MJ, Kerr T, Mathias R, Zhang R, Montaner JS, Tyndall M, Wood E.

    Am J Drug Alcohol Abuse. 2008;34(4):499-509.PMID: 18584579 [PubMed - indexed for MEDLINE]Related articles

    42.

    Prevalence and correlates of jugular injections among injection drug users.

    Hoda Z, Kerr T, Li K, Montaner JS, Wood E.

    Drug Alcohol Rev. 2008 Jul;27(4):442-6.PMID: 18584397 [PubMed - indexed for MEDLINE]Related articles

    43.

    A review of barriers and facilitators of HIV treatment among injection drug users.

    Wood E, Kerr T, Tyndall MW, Montaner JS.

    AIDS. 2008 Jul 11;22(11):1247-56. Review.PMID: 18580603 [PubMed - indexed for MEDLINE]Related articles

    44.

    The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility.

    Wood E, Kerr T, Tyndall MW, Montaner JS.

    Int J Drug Policy. 2008 Jun;19(3):220-5.PMID: 18551754 [PubMed - indexed for MEDLINE]Related articles

    45.

    Liver ultrastructural morphology and mitochondrial DNA levels in HIV/hepatitis C virus coinfection: no evidence of mitochondrial damage with highly active antiretroviral therapy.

    Matsukura M, Chu FF, Au M, Lu H, Chen J, Rietkerk S, Barrios R, Farley JD, Montaner JS, Montessori VC, Walker DC, Côté HC.

    AIDS. 2008 Jun 19;22(10):1226-9.PMID: 18525271 [PubMed - indexed for MEDLINE]Related articles

    46.

    Outcomes of multidrug-resistant patients switched from enfuvirtide to raltegravir within a virologically suppressive regimen.

    Harris M, Larsen G, Montaner JS.

    AIDS. 2008 Jun 19;22(10):1224-6.PMID: 18525270 [PubMed - indexed for MEDLINE]Related articles

    47.

    Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.

    Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, Montaner JS.

    J Infect Dis. 2008 Jul 1;198(1):59-67.PMID: 18498241 [PubMed - indexed for MEDLINE]Related articles

    48.

    Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.

    Lima VD, Gill VS, Yip B, Hogg RS, Montaner JS, Harrigan PR.

    J Infect Dis. 2008 Jul 1;198(1):51-8.PMID: 18498238 [PubMed - indexed for MEDLINE]Related articles

    49.

    Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.

    Wood E, Kerr T, Zhang R, Guillemi S, Palepu A, Hogg RS, Montaner JS.

    HIV Med. 2008 Aug;9(7):503-7. Epub 2008 May 15.PMID: 18484977 [PubMed - indexed for MEDLINE]Related articles

    50.

    Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth.

    Wood E, Stoltz JA, Zhang R, Strathdee SA, Montaner JS, Kerr T.

    Drug Alcohol Rev. 2008 May;27(3):270-6.PMID: 18368608 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...